Clinical experience with two etanercept biosimilars in Indian patients with spondyloarthritis
Background: Antitumor necrosis factor (TNF) drugs are highly efficacious in spondyloarthritis (SpA). We present retrospective analysis of our experience with 2 etanercept biosimilars (Etacept and Intacept). Methods: Clinical record of patients with axial and/or peripheral SpA (Assessment of SpA Inte...
Saved in:
Main Authors: | Ashok Kumar, Anshul Goel, Mehul Lapsiwala, Mohit Goyal, Gaurav Dembla |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-01-01
|
Series: | Indian Journal of Rheumatology |
Subjects: | |
Online Access: | http://www.indianjrheumatol.com/article.asp?issn=0973-3698;year=2017;volume=12;issue=3;spage=139;epage=145;aulast=Kumar |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Efficacy, safety, and immunogenicity of biosimilars compared with the biologic etanercept in patients with rheumatoid arthritis: a systematic review and meta-analysis
by: Aurélio Matos Andrade, et al.
Published: (2024-11-01) -
New Pharmacological Insight into Etanercept and Pregabalin in Allodynia and Nociception: Behavioral Studies in a Murine Neuropathic Pain Model
by: Loulwah Alothman, et al.
Published: (2024-11-01) -
Spondyloarthritis in India
by: Anand N Malaviya
Published: (2020-01-01) -
Effect of Integrin Blockade on Experimental Spondyloarthritis
by: Enoch Yau, et al.
Published: (2024-10-01) -
Ustekinumab Biosimilars
by: Elena Carmona-Rocha, et al.
Published: (2024-11-01)